Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 504.01 · gapped below the open, then crossed back over prior close. High/low 504.19 at 10:45 am ET, 500.34 at 3:45 pm ET.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of UTHR revenue | Skew |
|---|---|---|---|
| BETABETA Technologies, Inc. | 16.00% | 0.18% | 89× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Lilly manufactures and supplies Adcirca for us.”
FILING10-K0001082554-26-000006cik 0001082554
“We have also completed successful cargo and logistics demonstrations with medical partners and customers such as UPS and United Therapeutics Corporation ("United Therapeutics").”
FILING10-K0001628280-26-015838cik 0001784570disclosed by BETA
“We have a license agreement with United Therapeutics Corporation to use one of our proprietary technologies in an oral formulation of treprostinil diethanolamine, or treprostinil, for the treatment of pulmonary arterial hypertension and for other indications.”
FILING10-K0001356576-25-000017cik 0001356576disclosed by SUPN
“We pay DEKA product fees and a single-digit royalty on net product sales of the Remunity and RemunityPRO Pumps and Remodulin for use with these pumps.”
FILING10-K0001082554-26-000006cik 0001082554
“In June 2023, our third-party contract manufacturer, Gilero LLC, which was later acquired by Sanner GmbH, obtained FDA clearance for a cartridge to be used with the MS-3 pump for subcutaneous infusion of Remodulin.”
FILING10-K0001082554-26-000006cik 0001082554
“Finally, we rely entirely on Sanner GmbH to manufacture cartridges that were cleared by the FDA for use with the MS-3 pump to administer Remodulin.”
FILING10-K0001082554-26-000006cik 0001082554
“We also pay The Scripps Research Institute a one percent royalty on sales of Unituxin.”
FILING10-K0001082554-26-000006cik 0001082554
“The treprostinil used to produce Tyvaso DPI is supplied to us at no cost by United Therapeutics.”
FILING10-K0001193125-26-073516cik 0000899460disclosed by MNKD
“In the United States, we derive substantially all our treprostinil-based revenues from sales to two distributors, Accredo and CVS Specialty.”
FILING10-K0001082554-26-000006cik 0001082554
“Under this agreement, we sell Unituxin to Cencora at a transfer price that we establish, and we pay Cencora fees for services provided in connection with the distribution and support of Unituxin.”
FILING10-K0001082554-26-000006cik 0001082554
“In the United States, we derive substantially all our treprostinil-based revenues from sales to two distributors, Accredo and CVS Specialty.”
FILING10-K0001082554-26-000006cik 0001082554
“Our primary distributor outside the United States is Grupo Ferrer Internacional, S.A. ( Ferrer ), which holds Remodulin marketing authorization rights in many of these territories.”
FILING10-K0001082554-26-000006cik 0001082554
“We also sell Nebulized Tyvaso exclusively through Mochida Pharmaceutical Co., Ltd. ( Mochida ), in Japan, where the product was approved to treat PAH in late 2022, and to treat PH-ILD in 2024.”
FILING10-K0001082554-26-000006cik 0001082554
“We distribute Unituxin in Japan exclusively through Ohara Pharmaceutical Co., Ltd., which obtained Japanese marketing authorization during the second quarter of 2021.”
FILING10-K0001082554-26-000006cik 0001082554
“In 2022, ICU Medical discontinued manufacturing and distribution of the CADD-Legacy system used to administer intravenous Remodulin.”
FILING10-K0001082554-26-000006cik 0001082554
“We developed this product under an in-license from MannKind Corporation ( MannKind ) and launched this product commercially in the United States in June 2022.”
FILING10-K0001082554-26-000006cik 0001082554
“Under our agreement with Arena Pharmaceuticals, Inc., we will owe a low double-digit, tiered royalty on net product sales of ralinepag (for any route of administration), plus certain milestone payments upon defined regulatory events.”
FILING10-K0001082554-26-000006cik 0001082554
“We rely entirely on DEKA and its affiliates to manufacture the Remunity and RemunityPRO Pumps.”
FILING10-K0001082554-26-000006cik 0001082554
“We rely on two contract manufacturers — Forj Medical and Phillips-Medisize Corp. — to manufacture the Tyvaso Inhalation System for Nebulized Tyvaso.”
FILING10-K0001082554-26-000006cik 0001082554
“We rely on two contract manufacturers — Forj Medical and Phillips-Medisize Corp. — to manufacture the Tyvaso Inhalation System for Nebulized Tyvaso.”
FILING10-K0001082554-26-000006cik 0001082554
“In October 2024, we entered into a collaboration agreement with Robinson Helicopter Company to support our efforts to develop and certify zero-emission, hydrogen-electric powered helicopters based on Robinson's R44 and R66 helicopter models.”
FILING10-K0001082554-26-000006cik 0001082554
“In response, we funded Smiths Medical's manufacture of several thousand additional MS-3 pumps and, in parallel, pursued development of the Remunity Pump so that PAH patients would not experience a delay or disruption in their Remodulin therapy .”
FILING10-K0001082554-26-000006cik 0001082554
“Johns Hopkins University ( JHU ), New York University ( NYU ), the University of Alabama at Birmingham ( UAB ), and the University of Maryland, Baltimore ( UMB ) performed preclinical testing of our porcine xenografts in animal models.”
FILING10-K0001082554-26-000006cik 0001082554
“Johns Hopkins University ( JHU ), New York University ( NYU ), the University of Alabama at Birmingham ( UAB ), and the University of Maryland, Baltimore ( UMB ) performed preclinical testing of our porcine xenografts in animal models.”
FILING10-K0001082554-26-000006cik 0001082554
Watchlist prices, news filtered to it, and its next report on your desk.
United Therapeutics Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
United Therapeutics Corp has 19 disclosed suppliers and 7 disclosed customers. Each one is named in an SEC filing, either United Therapeutics Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
UTHR (United Therapeutics Corp) has 19 disclosed suppliers and 7 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: MNKD −5.20%, in the health bundle.